Regis Technologies
Katie Kretschmer is a skilled quality assurance professional with extensive experience in the biopharmaceutical industry. Currently serving as a Quality Assurance Associate at Regis Technologies since June 2023, Katie previously held the position of Senior Quality Control Analyst at Novartis Gene Therapies from February 2020 to January 2023, where responsibilities included implementing organized document systems and preparing GMP lot releases. Previously, positions included QA Batch Release Associate and Quality Assurance Document Processor at AveXis, Inc., and Associate Quality Assurance Specialist at Medline Industries, Inc. Katie's experience spans various roles in quality control and assurance, demonstrating a strong focus on compliance with cGMP standards, documentation, and batch review processes. Academic qualifications include a Bachelor of Arts in Art History and Ceramics from the University of Wisconsin-Whitewater.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.